{"id":"https://openalex.org/W2084480947","doi":"https://doi.org/10.1046/j.1471-4159.1995.65020770.x","title":"Selective Increase in Dopamine Utilization in the Shell Subdivision of the Nucleus Accumbens by the Benzodiazepine Inverse Agonist FG 7142","display_name":"Selective Increase in Dopamine Utilization in the Shell Subdivision of the Nucleus Accumbens by the Benzodiazepine Inverse Agonist FG 7142","alternate_titles":[],"publication_year":1995,"publication_date":"1995-08-01","ids":{"openalex":"https://openalex.org/W2084480947","doi":"https://doi.org/10.1046/j.1471-4159.1995.65020770.x","mag":"2084480947","pmid":"https://pubmed.ncbi.nlm.nih.gov/7616234"},"language":"en","primary_location":{"id":"doi:10.1046/j.1471-4159.1995.65020770.x","doi":"https://doi.org/10.1046/j.1471-4159.1995.65020770.x","is_oa":false,"landing_page_url":"https://doi.org/10.1046/j.1471-4159.1995.65020770.x","pdf_url":null,"source":{"id":"https://openalex.org/S135837084","display_name":"Journal of Neurochemistry","issn_l":"0022-3042","issn":["0022-3042","1471-4159"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Neurochemistry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2084480947"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5074837224","display_name":"Brian A. Horger","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Brian A. Horger","raw_affiliation_strings":["Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06520-8066, USA","Departments of Pharmacology and Psychiatry, Yale University School of Medicine, New Haven, Connecticut, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06520-8066, USA","institution_ids":["https://openalex.org/I32971472"]},{"raw_affiliation_string":"Departments of Pharmacology and Psychiatry, Yale University School of Medicine, New Haven, Connecticut, U.S.A","institution_ids":["https://openalex.org/I32971472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027557843","display_name":"John D. Elsworth","orcid":"https://orcid.org/0000-0002-0323-0886","observed_orcids":["https://orcid.org/0000-0002-0323-0886"]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"John D. Elsworth","raw_affiliation_strings":["Departments of Pharmacology and Psychiatry, Yale University School of Medicine, New Haven, Connecticut, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Pharmacology and Psychiatry, Yale University School of Medicine, New Haven, Connecticut, U.S.A","institution_ids":["https://openalex.org/I32971472"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111821114","display_name":"Robert Howard Roth","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Robert H. Roth","raw_affiliation_strings":["Departments of Pharmacology and Psychiatry, Yale University School of Medicine, New Haven, Connecticut, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Pharmacology and Psychiatry, Yale University School of Medicine, New Haven, Connecticut, U.S.A","institution_ids":["https://openalex.org/I32971472"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5074837224"],"corresponding_institution_ids":["https://openalex.org/I32971472"],"apc_list":{"value":5330,"currency":"USD","value_usd":5330},"apc_paid":null,"fwci":1.705,"has_fulltext":false,"cited_by_count":42,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.83483806,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":93},"biblio":{"volume":"65","issue":"2","first_page":"770","last_page":"774"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.9765999913215637,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.9765999913215637,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.021900000050663948,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13047","display_name":"Pharmacological Receptor Mechanisms and Effects","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fg-7142","display_name":"FG 7142","score":0.9940000176429749},{"id":"https://openalex.org/keywords/benzodiazepine-inverse-agonist","display_name":"benzodiazepine inverse agonist","score":0.9459999799728394},{"id":"https://openalex.org/keywords/dopamine-utilization","display_name":"dopamine utilization","score":0.7590000033378601},{"id":"https://openalex.org/keywords/nucleus-accumbens","display_name":"nucleus accumbens","score":0.8740000128746033},{"id":"https://openalex.org/keywords/dopac","display_name":"DOPAC","score":0.9440000057220459},{"id":"https://openalex.org/keywords/dopamine-metabolism","display_name":"dopamine metabolism","score":0.8479999899864197},{"id":"https://openalex.org/keywords/medial-prefrontal-cortex","display_name":"medial prefrontal cortex","score":0.9369999766349792},{"id":"https://openalex.org/keywords/dopamine-release","display_name":"dopamine release","score":0.843999981880188}],"concepts":[{"id":"https://openalex.org/C2776552330","wikidata":"https://www.wikidata.org/wiki/Q1476178","display_name":"Nucleus accumbens","level":3,"score":0.9856668710708618},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.7705838680267334},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6279311776161194},{"id":"https://openalex.org/C2778187257","wikidata":"https://www.wikidata.org/wiki/Q464210","display_name":"Basal ganglia","level":3,"score":0.5406463146209717},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4211651384830475},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4073895812034607},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.33827415108680725},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3229268491268158},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.20977729558944702},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.13466885685920715},{"id":"https://openalex.org/C529278444","wikidata":"https://www.wikidata.org/wiki/Q47273","display_name":"Central nervous system","level":2,"score":0.13233399391174316}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002243","descriptor_name":"Carbolines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004298","descriptor_name":"Dopamine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009714","descriptor_name":"Nucleus Accumbens","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D014018","descriptor_name":"Tissue Distribution","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015102","descriptor_name":"3,4-Dihydroxyphenylacetic Acid","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017397","descriptor_name":"Prefrontal Cortex","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058785","descriptor_name":"GABA-A Receptor Agonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1046/j.1471-4159.1995.65020770.x","doi":"https://doi.org/10.1046/j.1471-4159.1995.65020770.x","is_oa":false,"landing_page_url":"https://doi.org/10.1046/j.1471-4159.1995.65020770.x","pdf_url":null,"source":{"id":"https://openalex.org/S135837084","display_name":"Journal of Neurochemistry","issn_l":"0022-3042","issn":["0022-3042","1471-4159"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Neurochemistry","raw_type":"journal-article"},{"id":"pmid:7616234","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7616234","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of neurochemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1717630572","display_name":null,"funder_award_id":"MH14092","funder_id":"https://openalex.org/F4320337346","funder_display_name":"National Institute of Mental Health"}],"funders":[{"id":"https://openalex.org/F4320337346","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1975390997","https://openalex.org/W2138129388","https://openalex.org/W2050760271","https://openalex.org/W2083861794","https://openalex.org/W2164973759","https://openalex.org/W2017851636","https://openalex.org/W1998304611","https://openalex.org/W1971985706","https://openalex.org/W1966490713","https://openalex.org/W2036402734"],"abstract_inverted_index":{"We":[0],"examined":[1],"the":[2,5,15,21,49,86,92,108,112,124,128,149],"effects":[3],"of":[4,20,67,97,111,117,127,139],"benzodiazepine":[6],"inverse":[7],"agonist":[8],"FG":[9,24,79,101,118,153],"7142":[10,25,80,102,119,154],"on":[11,120],"dopamine":[12,68,83,105,121,146],"metabolism":[13],"in":[14,85,107,123,137,140,148],"core":[16,56,125],"and":[17,57,62,69],"shell":[18,58,109],"subdivisions":[19,98],"nucleus":[22,51,94,113,129,150],"accumbens.":[23,95,114],"(15":[26],"mg/kg":[27],"i.p.)":[28],"or":[29],"vehicle":[30],"was":[31,131],"administered":[32],"to":[33],"adult":[34],"male":[35],"rats":[36],"30":[37],"min":[38],"before":[39],"they":[40],"were":[41,60],"killed.":[42],"Selected":[43],"brain":[44],"regions,":[45],"including":[46],"samples":[47],"from":[48],"whole":[50,93],"accumbens":[52,130,151],"as":[53,55],"well":[54],"subdivisions,":[59],"collected":[61],"assayed":[63],"for":[64],"tissue":[65],"concentrations":[66],"its":[70],"major":[71],"metabolite,":[72],"3,4-dihydroxyphenylacetic":[73],"acid.":[74],"Consistent":[75],"with":[76],"previous":[77],"reports,":[78],"administration":[81],"increased":[82,104,145],"utilization":[84,106,122],"medial":[87],"prefrontal":[88],"cortex":[89],"but":[90],"not":[91],"Examination":[96],"revealed":[99],"that":[100],"produced":[103],"subdivision":[110],"No":[115],"effect":[116],"region":[126],"observed.":[132],"These":[133],"data":[134],"are":[135],"discussed":[136],"terms":[138],"vivo":[141],"microdialysis":[142],"studies":[143],"reporting":[144],"release":[147],"after":[152],"administration.":[155]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2084480947","counts_by_year":[{"year":2016,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}
